MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s2352-3026(24)00098-x

Медицинская библиотека · The Lancet. Haematology · 2024

Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT.

Pagliuca Simona, Schmid Christoph, Santoro Nicole, Simonetta Federico, Battipaglia Giorgia, Guillaume Thierry, Greco Raffaella, Onida Francesco, Sánchez-Ortega Isabel, Yakoub-Agha Ibrahim, Kuball Jurgen, Hazenberg Mette D, Ruggeri Annalisa, Practice Harmonization and Guidelines Committee and the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

СтатьяОбзорПеревод в очереди

Аннотация

Since the early description of three patients with relapsed leukaemia after allogeneic haematopoietic cell transplantation (HCT) who obtained complete remission after donor lymphocyte infusions (DLIs), the added value of this procedure to induce or maintain graft-versus-leukaemia immunity has been undisputed. For more than 30 years, DLIs have become common practice as prophylactic, pre-emptive, or therapeutic immunotherapy. However, as with many aspects of allogeneic HCT, centres have developed their own routines and practices, and many questions related to the optimal applications and toxicity, or to the immunobiology of DLI induced tumour-immunity, remain. As a part of the Practice Harmonization and Guidelines Committee and the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation effort, a panel of experts with clinical and translational knowledge in transplantation immunology and cellular therapy met during a 2-day workshop in September, 2023, in Lille, France, and developed a set of consensus-based recommendations for the application of unmanipulated DLI after allogeneic HCT for haematological malignancies. Given the absence of prospective data in the majority of publications, these recommendations are mostly based on retrospective studies and expert consensus.

Для цитирования: Pagliuca Simona, Schmid Christoph, Santoro Nicole, Simonetta Federico, Battipaglia Giorgia, Guillaume Thierry, Greco Raffaella, Onida Francesco, Sánchez-Ortega Isabel, Yakoub-Agha Ibrahim, Kuball Jurgen, Hazenberg Mette D, Ruggeri Annalisa, Practice Harmonization and Guidelines Committee and the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT.. The Lancet. Haematology. 2024. DOI: 10.1016/s2352-3026(24)00098-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.